Błąd cURL: Failed connect to www.viamedica.pl:443; No route to host
Vol 69, No 3 (2018)
Review paper
Published online: 2018-06-25

open access

Page views 4613
Article views/downloads 3381
Get Citation

Connect on Social Media

Connect on Social Media

Thyroid hormones and obesity: a known but poorly understood relationship

Pablo García-Solís1, Olga P. García2, Gabriela Hernández-Puga1, Ana A. Sánchez-Tusie1, Carlos E. Sáenz-Luna1, Hebert L. Hernández-Montiel1, Juan C. Solis-S1
Pubmed: 29952420
Endokrynol Pol 2018;69(3):292-303.

Abstract

Hormony tarczycy (thyroid hormones, TH) są zaangażowane w wiele różnych procesów biologicznych, wliczając rozwój układu nerwowego, regulację metabolizmu pośredniego oraz zużycie energii. Aktywnie uczestniczą w podstawowym zużyciu energii i termogenezie adaptacyjnej i z tego względu mogą mieć wpływ na masę ciała w przebiegu chorób tarczycy. Otyłość to niezakaźna, przewlekła, zapalna choroba metaboliczna, która implikuje dodatni bilans energetyczny. Tkanka tłuszczowa produkuje szereg hormonów i adipocytokin, takich jak leptyna, które mogą wpływać na stan tarczycy na różnych poziomach. Istnieją dowody na to, że dysfunkcja tarczycy może predysponować do otyłości i odwrotnie, istnieją dowody sugerujące, że otyłość powoduje zmiany dotyczące tarczycy. Celem tej pracy było opisanie związku między układem tarczycy a otyłością. Ponadto w pracy zaprezentowano hipotetyczny model podkreślający znaczenie obwodowej dejodynacji hormonów tarczycy i jego rolę w ustanowieniu dodatniego bilansu energetycznego. Podsumowując, możemy stwierdzić, że relacja między układem tarczycy a otyłością i nadwagą jest złożona i obejmuje wiele poziomów interakcji. Ponadto, poddając ocenie otyłego pacjenta, powinno się rozważyć ocenę funkcji tarczycy, aby uzyskać lepsze i spersonalizowane efekty leczenia.

Article available in PDF format

View PDF Download PDF file

References

  1. Kopp P, Solís JC. Thyroid hormone synthesis. In: Wondisford FE, Radovick S. ed. Clinical management of thyroid disease. Saunders Elsevier, Philadelphia 2009: 19–41.
  2. WHO | Obesity: preventing and managing the global epidemic [Internet]. WHO. 2017. http://www.who.int/entity/nutrition/publications/obesity/WHO_TRS_894/en/index.html (21.03.2017).
  3. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid. 2008; 18(2): 141–144.
  4. Solís-S JC, Valverde C. Neonatal hypothyroidism. pathophysiogenic, molecular and clinical aspects]. Rev Invest Clin. 2006; 58(4): 318–334.
  5. Valverde R, Orozco A, Solís J, Robles L. Iodothyronine deiodinases: emerging clinical crossroads. In: Conn M, Ulloa A. ed. Cellular endocrinology in health and disease. Elsevier, Massachusetts 2014: 365–377.
  6. Solís-S JC, Orozco A, García C, et al. Bioactivity of thyroid hormones. Clinical significance of membrane transporters, deiodinases and nuclear receptors]. Rev Invest Clin. 2011; 63(3): 287–308.
  7. Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, et al. Hypothalamus-Pituitary-Thyroid Axis. Compr Physiol. 2016; 6(3): 1387–1428.
  8. Vella KR, Hollenberg AN. The actions of thyroid hormone signaling in the nucleus. Mol Cell Endocrinol. 2017; 458: 127–135.
  9. Zhu X, Cheng SY. Thyroid hormone nuclear receptors and molecular actions. principles of endocrinology and hormone action. Springer International Publishing 2016: 1–25.
  10. Germain P, Staels B, Dacquet C, et al. Overview of nomenclature of nuclear receptors. Pharmacol Rev. 2006; 58(4): 685–704.
  11. Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol. 2014; 10(10): 582–591.
  12. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010; 31(2): 139–170.
  13. Ayers S, Switnicki MP, Angajala A, et al. Genome-wide binding patterns of thyroid hormone receptor beta. PLoS One. 2014; 9(2): e81186.
  14. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001; 81(3): 1097–1142.
  15. Meruvu S, Ayers SD, Winnier G, et al. Thyroid hormone analogues: where do we stand in 2013? Thyroid. 2013; 23(11): 1333–1344.
  16. Somogyi V, Gyorffy A, Scalise TJ, et al. Endocrine factors in the hypothalamic regulation of food intake in females: a review of the physiological roles and interactions of ghrelin, leptin, thyroid hormones, oestrogen and insulin. Nutr Res Rev. 2011; 24(1): 132–154.
  17. Ortiga-Carvalho TM, Oliveira KJ, Soares BA, et al. The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies. J Endocrinol. 2002; 174(1): 121–125.
  18. Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol. 2013; 5 Suppl 1: 40–44.
  19. Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015; 64(1): 24–34.
  20. Yoshida T, Monkawa T, Hayashi M, et al. Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 1997; 232(3): 822–826.
  21. Obregon MJ. Adipose tissues and thyroid hormones. Front Physiol. 2014; 5: 479.
  22. Brent G. Mechanisms of thyroid hormone action. J Clin Invest. 2012; 122(9): 3035–3043.
  23. Delitala AP, Fanciulli G, Pes GM, et al. Thyroid Hormones, Metabolic Syndrome and Its Components. Endocr Metab Immune Disord Drug Targets. 2017; 17(1): 56–62.
  24. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014; 94(2): 355–382.
  25. Lee P, Swarbrick MM, Ho KKY. Brown adipose tissue in adult humans: a metabolic renaissance. Endocr Rev. 2013; 34(3): 413–438.
  26. McAninch EA, Bianco AC. Thyroid hormone signaling in energy homeostasis and energy metabolism. Ann N Y Acad Sci. 2014; 1311: 77–87.
  27. Obregón MJ. [Obesity, thermogenesis and thyroid hormones]. Rev Esp Obes. 2007; 5: 27–38.
  28. López M, Varela L, Vázquez MJ, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010; 16(9): 1001–1008.
  29. Solinas G. Molecular pathways linking metabolic inflammation and thermogenesis. Obes Rev. 2012; 13 Suppl 2: 69–82.
  30. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011; 378(9793): 804–814.
  31. Lakshman R, Elks CE, Ong KK. Childhood obesity. Circulation. 2012; 126(14): 1770–1779.
  32. Shamah-Levy T, Cuevas-Nasu L, Rivera-Dommarco J, Hernandez-Avila M. Encuesta nacional de salud y nutrición de medio camino. Resultados nacionales. Instituto Nacional de Salud Pública, Cuernavaca, México (MX) 2016.
  33. Baudrand R, Arteaga E, Moreno M. El tejido graso como modulador endocrino: Cambios hormonales asociados a la obesidad. Rev Med Chile. 2010; 138(10).
  34. Misra M. Obesity pharmacotherapy: current perspectives and future directions. Curr Cardiol Rev. 2013; 9(1): 33–54.
  35. Álvarez-Castro P, Sangiao-Alvarellos S, Brandón-Sandá I, et al. [Endocrine function in obesity]. Endocrinol Nutr. 2011; 58(8): 422–432.
  36. Samaan SH. [TSH levels in obese children without thyroidal pathology]. Rev Horiz Med. 2012; 12: 23–28.
  37. Gallagher EJ, LeRoith D. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev. 2015; 95(3): 727–748.
  38. Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev. 2012; 249(1): 218–238.
  39. Bilir B, Güldiken S, Tunçbilek N, et al. The effects of fat distribution and some adipokines on insulin resistance. Endokrynologia Polska. 2015.
  40. Pazaitou-Panayiotou K, Panagiotou G, Polyzos SA, et al. Serum adiponectin and insulin-like growth factor 1 in predominantly female patients with thyroid cancer: association with the histologic characteristics of the tumor. Endocr Pract. 2016; 22(1): 68–75.
  41. Marwaha RK, Tandon N, Garg MK, et al. Impact of body mass index on thyroid functions in Indian children. Clin Endocrinol (Oxf). 2013; 79(3): 424–428.
  42. de Moura Souza A, Sichieri R. Association between serum TSH concentration within the normal range and adiposity. Eur J Endocrinol. 2011; 165(1): 11–15.
  43. Ambrosi B, Masserini B, Iorio L, et al. Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects. J Endocrinol Invest. 2010; 33(9): 640–643.
  44. Agnihothri RV, Courville AB, Linderman JD, et al. Moderate weight loss is sufficient to affect thyroid hormone homeostasis and inhibit its peripheral conversion. Thyroid. 2014; 24(1): 19–26.
  45. Rumińska M, Witkowska-Sędek E, Majcher A, Pyrżak B. Thyroid function in obese children and adolescents and its association with anthropometric and metabolic parameters. In: Pokorski M. ed. Prospect in pediatric diseases medicine. advances in experimental medicine and biology. Springer, Cham 2016: 33–41.
  46. Bjergved L, Jørgensen T, Perrild H, et al. Thyroid function and body weight: a community-based longitudinal study. PLoS One. 2014; 9(4): e93515.
  47. Witkowska-Sędek E, Kucharska A, Rumińska M, et al. Thyroid dysfunction in obese and overweight children. Endokrynol Pol. 2017; 68(1): 54–60.
  48. Mohammad MS, Farage AH, Abdullah AA. Influence of primary hypothyroidism on serum leptin level. Iraqi Postgrad Med. 2010; 9: 120–124.
  49. Pearce EN. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012; 19(5): 408–413.
  50. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015; 38(12): 1249–1263.
  51. Galofre JC, Frühbeck G, Salvador J. Obesity and thyroid function: pathophysiological and therapeutic. Hot Thyroidol. 2010; 6: 1–22.
  52. Rinaldi S, Lise M, Clavel-Chapelon F, et al. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer. 2012; 131(6): E1004–E1014.
  53. Gierach M, Junik R. The effect of hypothyroidism occurring in patients with metabolic syndrome. Endokrynol Pol. 2015; 66(4): 288–294.
  54. Rotondi M, Leporati P, Rizza MI, et al. Raised serum TSH in morbid-obese and non-obese patients: effect on the circulating lipid profile. Endocrine. 2014; 45(1): 92–97.
  55. Santini F, Marzullo P, Rotondi M, et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014; 171(4): R137–R152.
  56. Santini F, Galli G, Maffei M, et al. Acute exogenous TSH administration stimulates leptin secretion in vivo. Eur J Endocrinol. 2010; 163(1): 63–67.
  57. Liu G, Liang L, Bray GA, et al. Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial. Int J Obes (Lond). 2017; 41(6): 878–886.
  58. Soriguer F, Valdes S, Morcillo S, et al. Thyroid hormone levels predict the change in body weight: a prospective study. Eur J Clin Invest. 2011; 41(11): 1202–1209.
  59. Villarroya F, Peyrou M, Giralt M. Transcriptional regulation of the uncoupling protein-1 gene. Biochimie. 2017; 134: 86–92.
  60. Arrojo E Drigo R, Fonseca TL, Werneck-de-Castro JP, et al. Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta. 2013; 1830(7): 3956–3964.
  61. Pan H, Guo J, Su Z. Advances in understanding the interrelations between leptin resistance and obesity. Physiol Behav. 2014; 130: 157–169.
  62. Araujo RL, Carvalho DP. Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance. J Bioenerg Biomembr. 2011; 43(1): 59–65.
  63. Araujo RL, Andrade BM, Padrón AS, et al. High-fat diet increases thyrotropin and oxygen consumption without altering circulating 3,5,3'-triiodothyronine (T3) and thyroxine in rats: the role of iodothyronine deiodinases, reverse T3 production, and whole-body fat oxidation. Endocrinology. 2010; 151(7): 3460–3469.
  64. Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid. 2013; 23(6): 646–653.
  65. Sari R, Balci MK, Altunbas H, et al. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol (Oxf). 2003; 59(2): 258–262.
  66. Yadav A, Deo N. Influence of leptin on immunity. Curr Immunol Rev. 2013; 9(1): 23–30.
  67. Marzullo P, Minocci A, Tagliaferri MA, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab. 2010; 95(8): 3965–3972.
  68. Rotondi M, Magri F, Chiovato L. Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab. 2011; 96(2): 344–346.
  69. Witting V, Bergis D, Sadet D, et al. Thyroid disease in insulin-treated patients with type 2 diabetes: a retrospective study. Thyroid Res. 2014; 7(1): 2.
  70. Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab. 2010; 95(8): 3614–3617.
Błąd cURL: Failed connect to www.viamedica.pl:443; No route to host